Overview Request Sample Pages Request Customization Download PDF
You are viewing: Canada Digital Pathology Market analysis
Part of: Digital Pathology Market (Global)

The Canada Digital Pathology Market was valued at $67.3 Million in 2026 and projected to reach to $122.7 Million by 2031, representing a compound annual growth rate of 12.8%. Canada's digital pathology market is positioned for sustained growth through 2031, driven by healthcare system modernization initiatives and increasing recognition of digital solutions' diagnostic efficiency.

Canada Digital Pathology Market (2026-2031) : Size and Share
logo-mobile
CAGR of
cagr-Chart
USD Million
MARKET SNAPSHOT
Market Size in USD 26.32 MN
Market Forecast in
CAGR
Forecast Period
Units Considered Value (USD MN)

Canada Digital Pathology Market Trends and Insights

  • This 12.8% compound annual growth rate reflects Canada's increasing adoption of digital pathology solutions across healthcare institutions, driven by modernization of diagnostic infrastructure and rising demand for remote pathology services.
  • Canada's healthcare system is progressively integrating whole slide imaging and AI-powered diagnostic tools to enhance laboratory efficiency and patient outcomes. The Canadian market benefits from strong government healthcare investments, advanced IT infrastructure, and a collaborative healthcare ecosystem that supports digital transformation.
  • Canada's pathology laboratories are increasingly transitioning from traditional microscopy to digital workflows, enabling faster turnaround times and improved diagnostic accuracy.
  • By 2031, Canada is expected to solidify its position as a key adopter of digital pathology technologies in North America, supported by regulatory frameworks and clinical validation initiatives that prioritize innovation in diagnostic imaging..

Key Market Statistics

  • CAGR (2026-2031) 12.8% CAGR
  • Market Size, 2026 ~USD 67.3 Million
  • Forecast, 2031 ~USD 122.7 Million
  • Country Canada

Canada Digital Pathology Market Overview

Strong Market Valuation :

Canada's digital pathology market is valued at $67.3 million in 2026, with significant expansion projected to $122.7 million by 2031, representing an 82% growth over five years.

Above-Global Growth Rate :

Canada's 12.8% CAGR outpaces the global digital pathology growth rate of 12.5%, indicating accelerated adoption and investment in Canadian healthcare institutions.

Infrastructure Modernization :

Canadian healthcare providers are prioritizing modernization of diagnostic infrastructure, with digital pathology solutions becoming integral to laboratory operations across provinces.

Remote Pathology Demand :

Rising demand for remote pathology services across Canada's geographically dispersed regions is driving adoption of digital solutions, particularly in rural and underserved areas.

Canada Digital Pathology Market Dynamics

  • Provincial health authorities are investing in digital infrastructure to improve pathology service accessibility across Canada's vast geography, with particular emphasis on enabling remote consultations and specialist collaboration.
  • The market will benefit from growing integration with electronic health records and laboratory information systems.
  • Regulatory support and funding from government healthcare programs will further accelerate adoption among hospitals, diagnostic laboratories, and academic medical centers throughout the country..

Related Ecosystem

Healthcare Analytics

Top Technologies
    Top Companies

      Healthcare It

      Top Technologies
        Top Companies

          Key Takeaways

          • Canada's digital pathology market is valued at $67.3 million in 2026 and will reach $122.7 million by 2031, representing an 82% increase over the forecast period.
          • Canada's 12.8% CAGR outpaces the global average of 12.5%, indicating accelerated market penetration and technology adoption within Canadian healthcare institutions.
          • Canada's pathology sector is transitioning to digital workflows driven by government healthcare modernization initiatives, remote diagnostics demand, and AI integration capabilities.
          • Canada's advanced IT infrastructure and regulatory environment position the country as a leading adopter of digital pathology solutions in North America through 2031.

          Digital Pathology Market Report Scope

          Report Metric Details
          Base Year 2026
          Fastest Growing Segment PHARMACEUTICAL & BIOTECHNOLOGY COMPANIES (End User)
          Forecast Period 2026–2031
          Growth Rate CAGR of 12.5% from 2026 to 2031
          Largest Segment ONCOLOGY (Therapeutic Area)
          Market Size Base Year (Billions) ~USD 1.59 (2026)
          Revenue Forecast (Billions) ~USD 2.86 (2031)
          Segments Covered Product, Type, Technology, Application, Therapeutic Area, End User

          Canada Digital Pathology Market Report Segmentation

          6 segment dimensions are covered across the global market.

          By Product

          • Hardware
          • Software
          • Storage Systems

          By Type

          • AI & Computational Pathology Software
          • Biomarker Discovery & Validation
          • Brightfield Scanners
          • Cloud Storage
          • Drug Discovery & Efficacy Studies
          • Enterprise Digital Pathology Solutions/Platforms
          • Fluorescence Scanners
          • Human Pathology
          • Hybrid Storage
          • Image Analysis Software
          • Image Management Software
          • On-Premise Storage
          • Other Pre-Clinical Research
          • Other Scanners
          • Peripherals & Accessories
          • Toxicology & Safety Assessment
          • Veterinary Pathology
          • Whole Slide Imaging Scanners
          • Workstations & Viewing Systems

          By Technology

          • AI-Enabled Digital Pathology
          • Conventional Digital Pathology

          By Application

          • Academic & Translational Research
          • Clinical Diagnostics
          • Clinical Trials
          • Education & Training
          • Other Applications
          • Pre-Clinical Research
          • Telepathology

          By Therapeutic Area

          • Gastrointestinal Disease
          • Hematology
          • Infectious Disease
          • Neurology
          • Oncology
          • Other Therapeutic Areas

          By End User

          • Academic & Research Institutes
          • Contract Research Organizations
          • Diagnostic & Reference Laboratories
          • Hospitals & Health Systems
          • Other End Users
          • Pharmaceutical & Biotechnology Companies
          • Veterinary Laboratories

          CANADA: DIGITAL PATHOLOGY MARKET, BY END USER, 2024–2031

          Segment20242025202620272028202920302031CAGR (%)
          ACADEMIC & RESEARCH INSTITUTES4.85.466.67.48.39.310.411.9
          CONTRACT RESEARCH ORGANIZATIONS5.76.47.189.110.211.613.112.9
          DIAGNOSTIC & REFERENCE LABORATORIES12.614.115.91820.32326.129.713.3
          HOSPITALS & HEALTH SYSTEMS18.220.322.725.428.5323640.612.3
          OTHER END USERS1.71.92.12.32.62.83.13.510.5
          PHARMACEUTICAL & BIOTECHNOLOGY COMPANIES8.69.71112.614.316.418.721.514.2
          VETERINARY LABORATORIES22.22.42.72.93.23.53.99.9
          TOTAL53.66067.375.685.195.9108.4122.712.8

          Target Audience

          • Healthcare Technology Vendors : Digital pathology solution providers need Canada-specific market data to develop localized go-to-market strategies, identify key hospital and laboratory customers, and forecast revenue potential.
          • Hospital and Laboratory Administrators : Canadian healthcare facility leaders require market insights to justify digital pathology investments, benchmark against peer institutions, and plan infrastructure modernization budgets.
          • Investment and Private Equity Firms : Investors evaluating healthcare technology opportunities in Canada need market sizing and growth projections to assess portfolio companies, identify acquisition targets, and evaluate market attractiveness.
          • Healthcare Consultants : Management consultants advising Canadian healthcare organizations need authoritative market data to support strategic recommendations, competitive analysis, and digital transformation roadmaps.
          • Government and Policy Makers : Provincial health authorities and federal healthcare agencies require market intelligence to inform funding decisions, regulatory frameworks, and healthcare technology adoption policies across Canada.

          Key Companies in the Canada Digital Pathology Market

          CompanyHQOwnershipStrongest segments
          NIKON CORPORATIONJapanPublic CompanyImaging Business (digital cameras and cinema cameras),Precision Equipment Business (FPD exposure equipment),Healthcare Business (life science solutions),
          PIXCELLDATAIsraelPrivate CompanyCore data/analytics platform subscriptions,Professional services & implementation,Value-added modules & advanced analytics,
          SUNQUEST INFORMATION SYSTEMSUnited StatesPrivate CompanyCore LIS (Sunquest Laboratory, Multi-Lab Networking, Collect),Pathology and Anatomic Pathology (PowerPath, CoPathPlus),Blood Bank and Transfusion Management,
          CERNER CORPORATIONUnited StatesPrivate CompanyCerner Millennium and core clinical/financial applications,HealtheIntent population health and data platform,CareAware and device connectivity solutions,
          ZENSAR TECHNOLOGIES LTDIndiaPublic CompanyDigital and Application Services,Cloud Infrastructure and Security,Experience, Brand, and Creative Services,
          DANAHER CORPORATIONUnited StatesPublic CompanyBiotechnology (bioprocessing, single-use, cell culture, filtration),Life Sciences (genomics, mass spec, imaging, lab automation),Diagnostics (clinical instruments, consumables, software),
          KONINKLIJKE PHILIPS N.V.NetherlandsPublic CompanyDiagnosis & Treatment (Imaging and Image-Guided Therapy),Connected Care (Monitoring, Enterprise Informatics, Sleep & Respiratory Care),Personal Health,
          SECTRA ABSwedenPublic CompanyImaging IT Solutions,Secure Communications,Business Innovation (orthopedics, education, precision diagnostics),
          HAMAMATSU PHOTONICS K.K.JapanPublic CompanyElectron Tube (incl. photomultiplier tubes and radiation/x-ray sensors),Opto-Semiconductor (photodiodes, APDs, SPADs, MPPC, UV/IR sensors),Imaging and Measurement Instruments (cameras, spectrometers, x-ray systems, software),
          QUANTERIX CORPORATIONUnited StatesPublic CompanyHD-X instrument and related assays/consumables,SR-X instrument and related assays/consumables,SP-X planar array platform and multiplex assays,
          FUJIFILM HOLDINGS CORPORATIONJapanPublic CompanyHealthcare (medical systems, CDMO, pharma, regenerative, cosmetics),Business Innovation (office, document solutions, graphic communications),Electronics (display, semiconductor materials, storage, industrial equipment),
          HOLOGIC, INC.United StatesPrivate CompanyDiagnostics (Aptima, Panther, ThinPrep, Rapid Fetal Fibronectin),Breast Health (3D mammography, biopsy, localization, treatment support),GYN Surgical (MyoSure, NovaSure, Fluent, Acessa, CoolSeal),
          AIFORIAFinlandPublic CompanyClinical AI suite (viewer + cancer diagnostics),Aiforia Create (AI model development platform),Services, customization, and other software,

          NIKON CORPORATION

          Nikon Corporation is a Japanese public company founded in 1917 with 19,928 employees, known for manufacturing imaging and optical products.

          PIXCELLDATA

          Pixcelldata is a private company founded in 2010 and based in Israel.

          SUNQUEST INFORMATION SYSTEMS

          Sunquest Information Systems is a private company founded in 1979 and based in the United States.

          CERNER CORPORATION

          Cerner Corporation is a private company founded in 1979 in the United States with 25,150 employees, specializing in healthcare information technology.

          ZENSAR TECHNOLOGIES LTD

          Zensar Technologies Ltd is an Indian public company founded in 1963 with 10,066 employees, providing IT services and solutions.

          DANAHER CORPORATION

          Danaher Corporation is a public company founded in 1969 in the United States with 59,000 employees, operating as a diversified conglomerate.

          KONINKLIJKE PHILIPS N.V.

          Koninklijke Philips N.V. is a Dutch public company founded in 1891 with 64,317 employees, operating as a global diversified technology corporation.

          SECTRA AB

          Sectra AB is a Swedish public company founded in 1957 with 1,365 employees, specializing in medical imaging and cybersecurity solutions.

          HAMAMATSU PHOTONICS K.K.

          Hamamatsu Photonics K.K. is a Japanese public company founded in 1953 with 6,601 employees, manufacturing photonic products and systems.

          QUANTERIX CORPORATION

          Quanterix Corporation is a public company founded in 2007 in the United States with 450 employees, specializing in biotech instrumentation.

          FUJIFILM HOLDINGS CORPORATION

          Fujifilm Holdings Corporation is a Japanese public company founded in 1934 with 73,526 employees, operating across imaging, healthcare, and materials sectors.

          HOLOGIC, INC.

          Hologic, Inc. is a private company founded in 1985 in the United States with 7,070 employees, specializing in medical diagnostics and imaging.

          AIFORIA

          Aiforia is a Finnish public company founded in 2013 with 76 employees, specializing in artificial intelligence solutions.

          Reasons to Buy this Report

          • Market-Specific Sizing Data : Access precise valuation figures for Canada's digital pathology market with verified 2026 baseline ($67.3M) and 2031 forecast ($122.7M), enabling accurate budget allocation and ROI projections.
          • Competitive Positioning Intelligence : Understand Canada's 12.8% CAGR relative to global 12.5% growth, identifying market acceleration opportunities and competitive advantages specific to the Canadian healthcare landscape.
          • Regional Adoption Insights : Gain detailed understanding of digital pathology adoption patterns across Canadian provinces, healthcare institutions, and diagnostic centers to inform market entry and expansion strategies.
          • Growth Driver Analysis : Identify key catalysts driving Canada's market growth including infrastructure modernization, remote service demand, and regulatory support to prioritize strategic initiatives.
          • Investment Decision Support : Make informed investment and partnership decisions with comprehensive Canada-specific market data, supporting business case development and stakeholder presentations.

          Frequently asked questions

          What is the current size of Canada's digital pathology market?

          Canada's digital pathology market is valued at $67.3 million in 2026 and is projected to grow to $122.7 million by 2031.

          What is the expected growth rate for digital pathology in Canada?

          Canada's digital pathology market is expected to grow at a compound annual growth rate (CAGR) of 12.8% from 2026 to 2031.

          What factors are driving digital pathology adoption in Canada?

          Canada's adoption is driven by government healthcare modernization investments, demand for remote diagnostic services, integration of AI-powered tools, and the need for improved laboratory efficiency and diagnostic accuracy.

          How does Canada's digital pathology market compare to global trends?

          Canada's 12.8% CAGR exceeds the global average of 12.5%, demonstrating faster market growth and stronger technology adoption within Canadian healthcare institutions.

          What is the forecast market size for Canada's digital pathology sector by 2031?

          Canada's digital pathology market is forecasted to reach $122.7 million by 2031, representing an 82% increase from the 2026 baseline of $67.3 million.

          RESEARCH METHODOLOGY

          This research study involved the extensive use of both primary and secondary sources. It involved the analysis of various factors affecting the industry to identify the segmentation types, industry trends, key players, the competitive landscape of market players, and key market dynamics such as drivers, opportunities, challenges, restraints, and key player strategies.

          Secondary Research

          This research study extensively utilized secondary sources, including directories, databases such as Dun & Bradstreet, Bloomberg Businessweek, and Factiva, as well as white papers, annual reports, and companies' house documents. The secondary research aimed to gather and analyze information for a comprehensive and commercially focused study of the digital pathology market, encompassing technical aspects and market dynamics. It also facilitated the identification of key players, market classification, industry trends, geographical markets, and significant market-related developments. Additionally, a database of prominent industry leaders was compiled through secondary research.

          Primary Research

          In the primary research process, various supply-side and demand-side sources were interviewed to obtain qualitative and quantitative information for this report. Primary sources from the supply side included industry experts such as CEOs, vice presidents, marketing and sales directors, technology & innovation directors, engineers, and related key executives from various companies and organizations operating in the digital pathology market. Primary sources from the demand side included personnel from pharmaceutical & biotechnology companies, hospitals, diagnostic laboratories, and academic & research institutes.

          Digital Pathology Market Size, and Share

          *Others include sales managers, marketing managers, and product managers.

          Note: Tiers are defined based on a company’s total revenue as of 2025: Tier 1 = > USD 1 billion, Tier 2 = USD 500 million to USD 1 billion, and Tier 3 = < USD 500 million.

          To know about the assumptions considered for the study, download the pdf brochure

          Market Size Estimation

          The total size of the digital pathology market was determined through data triangulation using the two approaches described below. After completing each approach, a weighted average was calculated based on the level of assumptions used in each approach.

          Digital Pathology Market Top Down and Bottom Up Approach

          Data Triangulation

          The size of the digital pathology market was estimated through segmental extrapolation using the bottom-up approach. The methodology used is as follows: -

          • Revenues for individual companies were gathered from public sources and databases.
          • Shares of leading players in the digital pathology market were gathered from secondary sources to the extent available. In certain cases, shares of digital pathology businesses have been determined through a detailed analysis of various parameters, including product portfolios, market positioning, selling prices, and geographic reach & strength. 
          • Individual shares or revenue estimates were validated through interviews with experts.
          • The total revenue in the digital pathology market was determined by extrapolating the market share data of major companies.

          Market Definition

          Digital pathology is an image-based information environment for managing and interpreting information generated from digitized glass slides. The process involves converting glass slides to digital pathology slides using digital pathology scanning solutions. A digital image is then generated, enabling high-resolution slide viewing.

          Key Stakeholders

          • Healthcare Institutions/Providers (Hospitals, Medical Groups, Physician Practices, Diagnostic Centers, Ambulatory Centers, and Outpatient Clinics)
          • Digital Pathology Organizations
          • Senior Management
          • Finance/Procurement Department
          • R&D Department
          • Healthcare Data Aggregators
          • Venture Capitalists
          • Government Agencies
          • Healthcare Startups, Consultants, and Regulators
          • Academic Medical Institutes

          Report Objectives

          • To define, describe, and forecast the digital pathology market based on product, type, technology, application, therapeutic area, end user, and region
          • To provide detailed information regarding the major factors influencing the market growth (such as drivers, restraints, opportunities, and challenges)
          • To analyze the micromarkets1 with respect to individual growth trends, prospects, and contributions to the overall digital pathology market
          • To analyze the opportunities for stakeholders and provide details of the competitive landscape for market leaders
          • To forecast the size of the market segments with respect to five main regions, namely, North America, Europe, the Asia Pacific, Latin America, the Middle East & Africa.
          • To profile the key players and analyze their market shares and core competencies2
          • To track and analyze competitive developments such as product launches & approvals, partnerships, agreements, and collaborations in the overall digital pathology market
          • To benchmark players within the market using the proprietary "Competitive Leadership Mapping" framework, which analyzes market players on various parameters within the broad categories of business and product strategy

          Available customizations:

          With the given market data, MarketsandMarkets offers customizations as per your company’s specific needs. The following customization options are available for the report:

          Company Information

          • Detailed analysis and profiling of additional market players (up to 5)

          Geographic Analysis

          • Further breakdown of the Rest of Asia Pacific digital pathology market into Taiwan, New Zealand, Thailand, Singapore, Malaysia, and other countries
          • Further breakdown of the Rest of Europe digital pathology market into Russia, Austria, Finland, Turkey, Norway, Poland, Portugal, Romania, Denmark, and other countries

           

          Get the Full Digital Pathology Market Report

          Full forecast, segment splits, and company analysis for all Digital Pathology Market.

          Download Sample Pages Buy Report

          METHODOLOGY

          Need a Tailored Report?

          Customize this report to your needs

          Get 10% FREE Customization

          Customize This Report
          Fact checked
          Cite this Research
          DMCA.com Protection Status